Liver Metastases

• CLINICAL_TRIALS withdrawal · 2025-09-18
  Clinical Trial Update: Study of Intra-Arterial Oxaliplatin Plus Capecitabine to Treat Liver Metastases From Colorectal Cancer [Phase 1, Phase 2]

  Clinical trial of intra-arterial oxaliplatin plus capecitabine for liver metastases from colorectal cancer has been terminated (Phase 1/Phas…

• CLINICAL_TRIALS withdrawal · 2017-03-03
  Clinical Trial Update: Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases [Phase 4]

  A Phase 4 clinical trial comparing radiofrequency ablation plus chemotherapy versus chemotherapy alone for patients with secondary liver can…

• CLINICAL_TRIALS withdrawal · 2017-01-31
  Clinical Trial Update: A Study to See if we Can Predict How Your Liver Tumor or Liver Metastases Will Respond to Trans-Arterial Embolization (TAE)

  A clinical trial evaluating whether factors can predict how liver tumors or liver metastases respond to trans-arterial embolization has been…

• CLINICAL_TRIALS withdrawal · 2015-06-09
  Clinical Trial Update: Response of Hepatic Tumors to Radioembolization [Phase 2]

  Phase 2 trial evaluating hepatic tumors (hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and liver metastases) after radioemboliz…

• CLINICAL_TRIALS withdrawal · 2014-12-04
  Clinical Trial Update: Chemoembolisation With CPT11 Loaded DC Bead With Cetuximab and 5FU/LV in First Line in Patients With KRAS Wildtype mCRC [NA]

  A first-line trial of irinotecan-loaded DC Bead chemoembolisation with cetuximab and 5-FU/leucovorin for KRAS wild-type metastatic colorecta…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS withdrawal · 2009-02-10
  Clinical Trial Update: Magnetic Resonance Imaging (MRI) Using Liverspecific Oral Contrast Agent in Metastatic Colorectal Cancer Patients

  A clinical trial evaluating a liver-specific oral contrast agent for MRI in metastatic colorectal cancer has been withdrawn.